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Background: Spices and herbs have been used in food since ancient times to give taste and flavor and also as
food preservatives and disease remedies. In Cameroon, the use of spices and other aromatic plants as food
flavoring is an integral part of dietary behavior, but relatively little is known about their antifungal potential.
The present work was designed to assess the antifungal properties of extracts from spices used in Cameroonian
dietary.
Methods: The in vitro antifungal activities of twenty three extracts from twenty one spices were assessed by the
broth micro-dilution method against eight fungi. Also, the in vivo activity of Olax subscorpioidea extract (the most
active extract) was evaluated in rat model of disseminated candidiasis due to Candida albicans by estimating the
fungal burden in blood and kidney.
Results: Seven extracts (30%) exhibited moderate to significant antifungal activities, inhibiting the growth of the
microorganisms at concentrations ranging from 0.048 to 0.39 mg/mL. Olax subscorpioidea extract exhibited the
highest antifungal activity particularly against Candida albicans and Candida tropicalis (MIC of 0.097 mg/mL and
0.048 mg/mL respectively). Sixteen extracts (70%) were weakly active (MICs > 6.25 mg/mL). Oral administration of
O. subscorpioidea extract at the dose 2 g/kg of body weight (bw) to artificially infected rats revealed a drop in the
number of colony forming units per milliliter (cfu/mL) of Candida albicans cells in the blood below the detection
limit (100 cfu/mL) while a modest decrease was observed in the kidney.
Conclusion: The present work shows that some of the spices studied possess interesting antifungal properties and
could be used to treat candidiasis. Among the plant species tested, Olax subscorpioidea displayed the most
promising result.
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Nowadays, fungal diseases have emerged and are being
increasingly recognized as important public health prob-
lems owing to an ever-expanding population of immuno-
compromised patients [1]. Fungal infections are usually
associated with Candida, Aspergillus and Cryptococcus
species but those due to Candida species represent the
main opportunistic fungal infections worldwide, leading
to high morbidity and mortality in the population [2].
These changes are linked to the growing population of* Correspondence: jpdzoyem@yahoo.fr
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unless otherwise stated.immuno-compromised patients. During the last three
decades, Candida albicans has been the most prevalent
pathogen in systemic fungal infections [3]. Presently
non albicans species of Candida account for more than
50% of fungal infections. The opportunistic yeast mostly
reported are C. albicans, tropicalis, C. krusei, parapsilo-
sis, C. kefyr, glabrata, C. dubliensis and C. rugosa and
Cryptococcus neoformans [4]. Although the antifungal
active principles are diverse and numerous, only few clas-
ses of antifungal agents are currently available to treat
yeast infections due to the high toxicity of many of them
[5]. The high morbidity and mortality rates associated with
opportunistic yeast infections indicate that current anti-
fungal therapy to combat candidiasis is still ineffective.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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the current arsenal of antifungal drugs is exceedingly short
and no new antifungal drugs are expected to reach the
market any time soon [6]. Therefore, the discovery of new
antimicrobial agents is still relevant. Among the potential
sources of new agents, plants have long been investigated
because they contain many bioactive compounds that can
be of interest in therapy. Because of their low toxicity,
there is growing interest in using spices as a source of bio-
active phytochemicals for their antimicrobial properties in
preventing pathogenic diseases, in addition to their flavor
and fragrance qualities [7]. Many studies have confirmed
the role of spices in health maintenance and promotion;
the major challenge is to provide scientific evidence.
Therefore intense research have been carried out over the
past decade, and scientific evidence is accumulating that
spices do have medicinal properties that alleviate symp-
toms or prevent disease [8,9]. Many studies have reported
the in vitro activities of herbs and spices against several
pathogen microorganisms. However, it has been shown
that many exciting products found to be highly active on
the level of the fungal cell (in vitro activity) were either ex-
cessively toxic or inactive when tested in vivo [10]. There-
fore, it is essential that the potential effectiveness of the
new therapy agent is also evaluated in animal models In
Cameroon, the use of spices and other aromatic plants as
food flavoring is an integral part of dietary behavior. To
the best of our knowledge no study has investigated the ef-
fects of Cameroonian spices against eight yeast pathogens.
Therefore, the present work was designed to assess the
in vitro and in vivo antifungal properties of extracts from
selected spices ethno-medicinally used in Cameroon.Methods
Ethics statement
Animal experiments were performed in this study accord-
ing to the guidelines set for the care and use of laboratory
animals and with the rules formulated under the Animal
Welfare Act by the United States Department of Agricul-
ture (USDA) and by adopting ARRIVE guidelines [11].Plant materials and extraction
The 21 spices investigated in this work were purchased
from Dschang local market, West Region of Cameroon
in March 2012 (Table 1). They were identified at the
Cameroonian National Herbarium where voucher speci-
mens were deposited under the reference number
quoted in Table 1. The powdered air-dried sample from
each plant was separately extracted with a mixture of
methanol-dichloromethane (3:1 V/V) for 48 h at room
temperature. The extract was then concentrated under
reduced pressure to give the crude extract. All extracts
were kept at 4°C until further use.Fungal strains and culture media
The microorganisms used in this study were Candida
albicans ATCC 9002, C. parapsilosis ATCC 22019, C.
tropicalis ATCC 750, C. krusei ATCC 6258, C. lusitaniae
ATCC 200950, (American Type Culture Collection), Cryp-
tococcus neoformans IP95026 (Institut Pasteur France)
and two clinical isolates namely C. guilliermondii and
C. glabrata (Centre Pasteur Yaounde-Cameroon). Sabour-
aud dextrose agar (SDA) (Liofilchem Laboratories) was
used for the maintenance and culture of fungal strains
while Sabouraud dextrose broth (SDB) was used for
the determination of the minimum inhibitory concentra-
tions (MICs) and the minimum fungicidal concentrations
(MFCs).
Antifungal assay
MIC and MFC determination
The MICs were determined using the rapid 2-(4-iodophe-
nyl)-3-(4-nitrophenyl)-5-phenyltetrazolium chloride (INT)
colorimetric assay [28]. Briefly, extracts were first emulsi-
fied in DMSO/SDB (50:50 V/V). The solution obtained
was then added to SDB, and serially diluted twofold mak-
ing each well to have a volume of 100 μL (in a 96- wells
microplate). One hundred microlitres (100 μL) of inocu-
lum (2.4 × 104 cfu/mL) prepared in SDB was then added.
Wells containing SDB, 100 μL of inoculum and DMSO at
a final concentration of 2.5% served as negative control.
Nystatin was used as reference antifungal drugs. The plate
was covered with a sterile plate sealer, then agitated to mix
the contents of the wells using a shaker and incubated at
37°C for 24 h. The final concentration of DMSO was 2.5%
and did not affect the microbial growth. The MICs of
samples were detected after 24 h (48 h for C. neoformans)
incubation at 37°C, following addition of 40 μL of a
0.2 mg/mL INT solution and further incubation at 37°C
for 30 minutes. Viable yeast microorganisms reduce the
yellow INT dye to pink. MIC was defined as the lowest
sample concentration that exhibited complete inhibition
of microbial growth and hence prevented this color
change. The MFC was determined by adding 50 μL of the
suspensions from the wells, which did not show any
growth after incubation during MIC assays, to 150 μL of
fresh broth. These suspensions were re-incubated at 37°C
for 48 h (72 h for C. neoformans). The MFC was deter-
mined as the lowest concentration of extract which com-
pletely inhibited the growth of yeast.
Effect of O. subscorpioidea extract on disseminated
candidiasis in rats
The in vivo antifungal assay was performed as described
by Richardson et al., [12] and Kretschmar et al., [13] with
slight modifications [29,30].
Experimental animals: Pathogen-free female albino
Wistar rats (6–8 weeks old) were used. These animals
Table 1 General information on the studied spices
Name of plant (Family) Ethno-medicinal uses Parts used Parts ed
in th ork
Extraction yield (%) Voucher number
Aframomum citratum (Pereira)
K. Schum. (ZINGIBERACEAE)
Fever, intercostals pains, tonic, aphrodisiac [12,13]. Fruits, barks and leaves Leav ruits 6.12 37736/NHC
Aframomum melegueta (Roscoe)
K. Schum. (ZINGIBERACEAE)
Constipation, fever, carminative [14]. Seeds and fruits Fruit 3.07 39065/HNC
Beilschmiedia cinnamomea (Stapf)
Robyns & R. Wilczek(LAURACEAE)
Not reported Not reported Barks 5.03 6933/SRF-Cam
Cinnamomum zeylanicum (Linn)
Cor. (LAURACEAE)
Stimulant, antiflatulent, antiemetic; antidiarrhoeal [13]. Barks and leaves Leav 5.81 22309/SRF-Cam
Dichrostachys glomerata (Forssk.)
Chiov. (MIMOSACEAE)
Headache, toothache, dysentery, elephantiasis, leprosy, syphilis,
coughs and, anthelmintic, purgative, strong diuretic, epilepsy, diuretic,
laxative, and the massage of fractures [15,16].
Fruits Fruit 6.68 15220/SRF-Cam
Dorstenia Psilirus Welwitch
(MORACEAE)
Arthralgia, cardiovascular disorders, rheumatism, snakebites, headache,
stomach disorders, diuretic, tonic, stimulant, analgesic, spice [13].
Leaves and roots Barks 16.52 44839/HNC
Echinops giganteus var. lelyi
(C. D.Adams) A. Rich. (COMPOSITAE)
Heart and gastric troubles spice. Calm stomach ache, give carminative
help and reduce the effects of alcohol, reduces asthma attacks [17,18].
Roots Root 2.76 23647/SRF-Cam
Fagara leprieurii (Guill and Perr)
Engl (RUTACEAE)
Abdominal pain, asthma, appendicitis, toothache spice. Gastritis, gingivitis.
Bilharzias, antidiarrhoeal, cancer, laxative, antimicrobial, ulcer, gonorrhea,
kidney ache, sterility [19].
Barks, seeds and fruits Fruit 5.26 37632/HNC
Fagara macrophylla Engl. (RUTACEAE) Colds and stomach-ache, fever. Malaria toothache, rheumatism,
and urogenital affections [13,20].
Barks, seeds and fruits Fruit 17.63 2716/SRFK-Cam
Imperata cylindrica Beauv. var. koenigii
Durand et Schinz (POACEAE)
Diuretic and anti-inflammatory agents [21]. Roots Root 13.07 30139/SRFK
Mondia whitei Hook. f. (OLACACEAE) Aphrodisiacs, urinary tract infection, jaundice and headaches
diarrhea [22].





Constipation, uterine hemorrhage, diuretic, fever [23,24]. Fruits Fruit 9.82 2949/SFR-Cam
Olax subscorpioidea var. subscorpioidea
Oliv. (OLACACEAE)
Constipation, yellow fever, jaundice, venereal diseases, Guinea worm [25]. Fruits, roots and seeds Fruit 14.95 3528/SRFK
Pentadiplandra brazzeana Baill.
(CAPPARACEAE)
Aphrodisiac, toothache, peptic ulcer, stomach painand hemorrhoids,
diarrhea spice [25].
Barks, roots Barks 3.81 42918/HNC
Piper capense L.f. (PIPERACEAE) Sleep inducing remedy, anthelmintic, spice [13]. Fruits Fruit 1.81 6018/SRF-Cam
Piper guineense Schum et Thom
(PIPERACEAE)
Respiratory infections, female infertility, aphrodisiac [22]. Fruits Fruit 10.6 6018/SRF-Cam
Scorodophloeus zenkeri Harms
(CAESALPINIACEAE)
Headache, cough, rheumatism; constipation [19]. Barks, seeds, woods,
fruits
Bark fruits 7.67 44803/HNC
Solanum melongena Hierm
(SOLANACEAE)
Treatment of syphilis; skin infection; gonorrhea; rheumatic disease
and swollen. [14]









































Table 1 General information on the studied spices (Continued)
Tetrapleura tetraptera (Schum and
Thonn) Taub. (MIMOSACEAE)
Tonic, purgative, emetic, convulsions, leprosy, anti-inflammatroy,
rheumatic pains, spice [13,26].
Fruits and barks Fruits 3.71 12117/SRF-Cam
Xylopia aethiopica (A. Rich)
Dunal (ANNONACEAE)
Headache, cough, rheumatism; constipation [19]. Barks, leaves, roots,
fruits
Fruits 18.19 16419/SRF-Cam
Xylopia parviflora (A. Rich.)
Benth (ANNONACEAE)
Stomach disorders, barrenness, headache relief,
analgesic and antispasmodic [27].
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Biochemistry, Faculty of Science of the University of
Dschang.
Induction of systemic infection with Candida albicans
in rat: Disseminated candidiasis infection was induced by
intravenous (i.v.) injection of 0.2 mL of a 106 UFC/mL
inoculum, prepared in sterile saline from a fresh 48 h
Candida albicans culture to rats. Twenty-four hours
after infection three animals were sacrificed to check
the effectiveness of the infection by assessing the fungal
load in the blood and kidneys. This in vivo study con-
formed to animal research: reporting in vivo experiment
guideline for reporting animal study (ARRIVE).
Antifungal treatment: Infected rats distributed into
five groups of 12 animals each were housed in cages and
had access to food and water ad libitum. Extract at the
doses of 0.5, 1 and 2 g/kg of bw, were administered i.v.
over three consecutive days, starting 24 h after infection.
Two control groups were used; untreated control received
distilled water and a positive control group treated with
reference antifungal drug nystatin at 10 mg/kg of bw.
Determination of viable yeasts in organ samples:
Twenty-four hours after the first, second and third treat-
ment (at days 2, 3 and 4 of infection) three animals in
each group were sacrificed by cervical dislocation; blood
and organ samples were collected from each rat. Kidney
tissues were homogenized in 5 mL of sterile saline, and
then serially diluted. Blood samples were also serially
diluted. 0.1 mL of each dilution was plated onto SDA
containing chloramphenicol, incubated for 24 h at 37°C
and the number of fungal colony were counted. The
lower limit of detection was 100 cfu/mL. The results
were expressed as log of the mean number of cfu/g of
tissue per three animals.
Statistical analysis
One way analysis of variance was used to analyze the
fungal load in animal tissues between each treatment
group and the control group. When there were differences
between groups, the means were compared using the
Student-Newman-Keuls test at a 5%. Results are expressed
as mean ± standard deviation. All data were analyzed using
SPSS Statistics 17.0.2.
Results and discussion
In vitro antifungal activity: Spices have been used for
generations by humans as food and to treat ailments. As
depicted in Table 1, spices used in this study are used
traditionally in the treatment of a wide range of diseases.
Many studies have confirmed their role in health main-
tenance and promotion, but the major challenge is to
provide scientific evidence [7]. Therefore, the in vitro
and in vivo antifungal potentials of 23 extracts from
spices used in Cameroonian dietary were investigated.The results of in vitro antifungal assay (MIC and MBC)
are presented in Table 2. The results indicated that all
the extracts demonstrated both fungistatic and fungicidal
activities with the minimum inhibitory concentration ran-
ging from 0.048 to 6.25 mg/mL and the minimum fungi-
cidal concentration ranging from 0.19 to 6.25 mg/mL.
Each of the extract tested in the present study displayed
antifungal activity on at least one of the 8 pathogen yeasts
tested. However differences were observed between anti-
fungal activities as most of the tested plant extracts
exerted a broad antifungal spectrum. These variations in
antifungal activity could be due to the differences in the
chemical composition of these spices as the secondary me-
tabolites of plants have many effects including antimicro-
bial properties [31]. In addition, the activity of the plant
extract could be influenced by the nature of the plant ma-
terial or its origin as well as the climatic conditions in
which plant grow, the plant part used, or the solvent used
for extraction, because plants have different constituents
depending on those factors [32].
Antimicrobial activity of plant extracts are routinely
classified on the basis of susceptibility tests that produce
MIC in the range of 100 to 1000 μg/mL [33]. The activity
is considered to be significant if MIC values are below
100 μg/mL for crude extract and moderate when the
MICs vary from 100 to 625 μg/mL [15,32]. Seven extracts
(30%) inhibited the growth of 6 studied yeasts from signifi-
cant to moderated extent while other extracts exhibited
weak activities. These results are supported by previous
studies reporting that the commonly used herbs and
spices possess antimicrobial properties that, in some cases,
can be used therapeutically [8]. Considering the fact that
the spices tested are used as food ingredients with limited
toxicity, the overall activity recorded with several ex-
tracts, especially those of A. citratum (leaves), D. glomerata,
D. psilirus, F. macrophylla and P. capense, could be consid-
ered important. The best activity was observed with the ex-
tract from O. subscorpioidea fruits showing significant to
moderate activity against five out of the eight opportunistic
yeast strains tested, with a particular strong effectiveness
against Candida albicans and Candida tropicalis (MIC
of 0.097 mg/mL and 0.048 mg/mL respectively). The ex-
tracts from C. zeylanicum leaves also showed significant
activity against Candida tropicalis (MIC of 0.097 mg/mL).
High antimicrobial activities of C. zeylanicum against clin-
ical strains of C. albicans from nosocomial infections were
previously reported [34]. Qualitative phytochemical ana-
lysis of O. subscorpioidea and C. zeylanicum revealed the
presence of alkaloids, anthraquinones, phenols, flavonoids,
tannins and triterpernes which could contribute to the ob-
served antifungal activities [35]. Many of the phytonutri-
ents found in spices act as potent preventive agents
against microbial diseases. It is generally found that plants
containing diverse classes of chemicals are of superior
Table 2 MIC and MFC (mg/mL) of 23 extracts from 21 Cameroonian spices against eight opportunistic yeasts fungi
Tested samples Microorganisms
Ca Cn Ct Ck Cp Cl. Cgu. Cgl
MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC
A. citratum (fr) - - 6.25 - 6.25 - - - 6.25 - 0.78 1.56 3.12 6.25 6.25 -
A. citratum (le) 3.12 - 0.19 6.25 6.25 6.25 0.39 6.25 6.25 - 0.78 0.78 3.12 - 3.12 -
A. melegueta 6.25 - 6.25 - 1.56 1.56 6.25 - 6.25 - 3.12 3.12 1.56 - - -
B. cinnamomea 3.12 3.12 3.12 6.25 3.12 - - - - - 3.12 - 6.25 - 6.25 6.25
C. zeylanicum 3.12 - 1.56 3.12 0.097 0.19 0.78 6.25 3.12 6.25 0.78 0.78 0.78 0.78 3.12 -
D. glomerata 0.39 6.25 0.78 - 3.12 3.12 3.12 3.12 6.25 - 0.39 6.25 3.12 6.25 3.12 6.25
D. psilirus 0.39 1.56 6.25 - 0.39 1.56 3.12 3.12 3.12 3.12 3.12 3.12 1.56 1.56 3.12 -
E. giganteus 6.25 - 3.12 - 6.25 6.25 - - 6.25 6.25 6.25 6.25 3.12 - 1.56 -
F. leprieurii 3.12 6.25 6.25 6.25 6.25 - 6.25 - 6.25 - - - - - 3.12 -
F. macrophylla 3.12 6.25 1.56 3.12 0.39 0.78 6.25 - - - 1.56 6.25 1.56 - 3.12 -
I. cylindrica 6.25 - 1.56 1.56 3.12 - 1.56 1.56 6.25 - 3.12 3.12 3.12 - 3.12 6.25
M. whitei 3.12 - - - 3.12 - - - - - 3.12 6.25 6.25 - - -
M. myristica 6.25 - 0.78 6.25 3.12 3.12 6.25 6.25 - - 3.12 6.25 3.12 - - -
O. subscorpioidea 0.097 0.19 0.39 1.56 0.048 0.19 1.56 6.25 0.39 1.56 0.19 0.39 0.78 - 1.56 6.25
P. brazzeana 3.12 6.25 6.25 6.25 1.56 1.56 - - - - 6.25 - 6.25 - 6.25 -
P. capense 3.12 - 1.56 1.56 0.19 3.12 3.12 6.25 3.12 6.25 1.56 1.56 3.12 - - -
P. guineense 3.12 3.12 3.12 - 3.12 - - - 6.25 - 1.56 - - - 3.12 -
S. zenkeri (fr) 1.56 - - - 6.25 - 6.25 - 6.25 6.25 1.56 6.25 6.25 - 3.12 6.25
S. zenkeri (bk) 3.12 - 3.12 - 3.12 - 1.56 6.25 6.25 - 3.12 6.25 6.25 - 6.25 -
S. melongena - - 3.1- - 3.12 3.12 - - - - - - 6.25 6.25 - -
T. tetraptera 3.12 - 3.12 - 6.25 6.25 6.25 - 3.12 6.25 3.12 - 3.12 - 6.25 -
X. aethiopica 3.12 6.25 6.25 6.25 3.12 6.25 3.12 3.12 3.12 3.12 - - - - - -
X. parviflora 6.25 - - - 3.12 - 3.12 3.12 3.12 3.12 1.56 1.56 3.12 6.25 6.25 -
Nystatin (μg/mL ) 78.1 31.2 195.3 78.1 4.8 19.5 6- 1-0 39 156 19.5 78.1 39 78.1 19.5 39
Ca: Candida albicans, Cn: Cryptococcus neoformans, Ct: Candida tropicalis, Ck: Candida krusei, Cp: Candida parapsilosis, Cl: Candida lusitaniae, Cgu: Candida
guilliermondii, Cgl: Candida glabrata, fr: fruits, le: leaves, bk: barks. -: > 6.25 mg/mL, le: leaves, fr: fruits, bk: barks, In bold are values for significant activity.
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the higher the diversity and the quantity of these chemical
classes a plant may contain, the stronger and broader the
spectrum of biological activities the plant molecules may
exhibit [36].
Among the eight pathogenic yeasts tested C. albicans
and Candida tropicalis were the most sensitive to the
extracts, while C. krusei and C. glabrata were the most
resistant. Since C. albicans is the most prevalent pathogen
in systemic fungal infections [3] and being the most suscep-
tible to O. subscorpioidea extract (MIC of 0.097 mg/mL)
in vitro, the in vivo therapeutic effect of O. subscorpioidea
extract was evaluated on systemic infection induced with
C. albicans in rats.
In vivo antifungal activity: The intravenous challenge
model was used to study invasive Candida infection.
Yeast cells were injected directly into the blood stream
through the lateral tail vein [37]. In this model, which
is similar to human invasive infection occurring withcatheter involvement, fungal cells are found in all or-
gans, but disease progresses mostly in the kidneys and
brain. It is well known that the kidney is the primary
target organ in systemic candidiasis; it is the major
organ in which the multiplication of Candida occurs
[38]. Therefore, the in vivo activity of extract from O.
subscorpioidea was evaluated in experimental systemic
candidiasis with C. albicans in rats, by estimating the
fungal burden in this organ as well as in blood. The re-
sults on the estimated number of viable C. albicans
cells in blood and kidneys from animals that were in-
fected intravenously with 1×106 cells/mL and treated
for three consecutive days with saline, extract (0.5, 1
and 2 g/kg of bw) are shown in Figures 1. The adminis-
tration of the extract caused a reduction of the fungal
load after 24 h both in the blood and in kidneys of in-
fected rats compare to untreated control. A significant
difference was observed (p < 0.05) in the decrease of


















































Figure 1 Variation of fungal burden of blood (A) and kidney (B) in rat model of disseminated candidiasis at various time intervals
upon treatment with extract Olax subscorpioidea and nystatin. Animals were infected intravenously with 106 cells/mL(Candida albicans) and
were treated for three consecutive days with saline, extract (0.5, 1 and 2 g/kg of bw) and nystatin (10 mg/kg of bw). The fungal burden was
assessed by determining the number of cfu.
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the number of cfu/mL in blood dropped below the de-
tection limit within 72 h, while the control (nystatin)
showed similar effect within 48 h. This result suggests
that C. albicans cells intravenously injected were rap-
idly cleared from the blood. The rapid disappearance
of C. albicans from the blood observed could be attrib-
uted to the combined killing effect of extract or nysta-
tin and the immune system cells. Our findings are in
agreement with those of Robert et al. [39], who re-
ported that after injection into the lateral tail veins of
mice, the rate of clearance of C. albicans from the
bloodstream was high, leading to the disappearance of
97% of the inoculated cells within the first minute. It
should also be noted that this observation could be ex-
plained further by the fact that some of the C. albicans
cells moved into the deep organs like the kidneys, be-
ing the primary target organ in systemic candidiasis
where the multiplication of C. albicans occurs [38]. As
shown in Figure 1B, compared to untreated infected
animals, extract reduced the level of fungal load in kid-
neys during treatment. After 3 days of treatment with
extract each of the test doses modestly reduced the
growth of fungi in the kidney. At the highest dose (2 g/kg
of bw), reduction in the log of cfu/g in the kidney was
more pronounced compared to the lower doses. Although
the reduction was not statistically significant, the result
obtained is important when compared to those obtained
with nystatin. Nevertheless, it is noteworthy that the result
obtained could be considered as significant bearing in
mind that C. albicans survival in the kidney plays a pri-
mary role in mortality in patients with disseminated
candidiasis [40]. Our results revealed that extract from
O. subscorpioidea displayed an inhibitory effect on fun-
gal proliferation in vivo. To the best of our knowledge,
the in vivo antifungal properties of spices are herein re-
ported for the first time. Therefore, a subject for future
investigation with a possible prolongation of the periodof treatment to 7 or 14 days to more accurately define
the preclinical significance of the in vivo data herein
observed.
The overall results obtained revealed that, extract from
spices in this study possess inhibitory effect on the
growth of pathogenic yeast. Olax subscorpioidea showed
the most promising activity in vitro and exerted inter-
esting anti-Candida effect against systemic candidiasis
in rat model. These findings emphasize the evidence
that increasing our intake in spices could be an alterna-
tive to prevention of infections from opportunistic fun-
gal yeast pathogens.Conclusion
The present study demonstrates the antifungal potential
of extracts from some Cameroonian spices and provides
the scientific evidence that natural spices could be used
for the prevention of yeast diseases.Competing interests
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